Addison Advisors LLC Merck & Co., Inc. Transaction History

Addison Advisors LLC

$340 Million
Q3 2024

A detailed history of Addison Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Addison Advisors LLC holds 5,861 shares of MRK stock, worth $581,235. This represents 0.2% of its overall portfolio holdings.

Number of Shares

5,861

Previous 6,246 6.16%

Holding current value

$581,235

Previous $773,000 13.97%

% of portfolio

0.2%

Previous 0.26%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$111.15 - $128.97 $42,792 - $49,653	-385 Reduced 6.16%	5,861 $665,000
Q2 2024 Aug 05, 2024	BUY	$123.8 - $132.96 $40,977 - $44,009	331 Added 5.6%	6,246 $773,000
Q4 2023 Feb 02, 2024	BUY	$100.18 - $109.02 $104,888 - $114,143	1,047 Added 21.51%	5,915 $644,000
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $823 - $914	-8 Reduced 0.16%	4,868 $501,000
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $37,687 - $41,077	-347 Reduced 6.64%	4,876 $562,000
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $27,999 - $31,241	-272 Reduced 4.95%	5,223 $555,000
Q4 2022 Feb 07, 2023	SELL	$87.44 - $112.11 $63,306 - $81,167	-724 Reduced 11.64%	5,495 $609,000
Q3 2022 Oct 28, 2022	BUY	$84.53 - $94.96 $3,550 - $3,988	42 Added 0.68%	6,219 $536,000
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $27,551 - $31,231	330 Added 5.64%	6,177 $563,000
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $77,479 - $86,849	1,054 Added 21.99%	5,847 $480,000
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $195,083 - $244,367	2,699 Added 128.89%	4,793 $367,000
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $716 - $788	10 Added 0.48%	2,094 $157,000
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $14,765 - $16,331	-210 Reduced 9.15%	2,084 $162,000
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $164,640 - $182,717	2,294 New	2,294 $188,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.

Account

Addison Advisors LLC Merck & Co., Inc. Transaction History